SYRE R&D Expense Growth
Spyre Therapeutics Inc · R&D Expense Growth
SYRE R&D Expense Growth
Latest reported5.44%period ending
SYRE FY R&D Growth (YoY) (0.00% → 5.44%)
Latest values, visible window
High-resolution chart · PNG
SYRE r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 5.4444% | |
| 81.8801% | |
| 52.792% | |
| 2.6459% | |
| -4.3077% | |
| -7.6811% | |
| 75.9307% | |
| 60.9424% | |
| 25.751% | |
| 58.4126% | |
| 67.6867% | |
| 0% | |
| 0% |